GlassScriptPhysician profile
Mohammad Irfan Jamil
NPI 1255419206
$1,546.66
in general payments reported to CMS, 2019-2025
23 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $182 · 2022: $148 · 2023: $323 · 2024: $422 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034 · Travel and Lodging: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.42 |
| Travel and Lodging | $183.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $183.01 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $173.44 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $165.69 | 2020-2025 | Otezla, Repatha, Krystexxa |
| Biotronik INC. | $147.66 | 2022 | |
| Inari Medical, INC. | $138.02 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $137.99 | 2023 | Corevalve Evolut R |
| Abbott Laboratories | $102.85 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $74.22 | 2024-2025 | Inspire |
| Akebia Therapeutics INC | $57.05 | 2020 | |
| Sanofi-Aventis U.S. LLC | $54.96 | 2024-2025 | |
| Atricure, INC. | $49.61 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Currax Pharmaceuticals LLC | $33.50 | 2023 | Contrave, Onzetra Xsail, Nexletol |
| Novo Nordisk INC | $32.71 | 2024 | Rybelsus, Ozempic |
| Edwards Lifesciences Corporation | $23.75 | 2025 | Sapien 3 Ultra Resilia |
| Nevro Corp. | $22.95 | 2023 | Senza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.71 | 2023 | Xarelto |
| Abbvie INC. | $22.14 | 2025 | |
| Glaxosmithkline, LLC. | $21.56 | 2023 | Arexvy, Shingrix |
| Exact Sciences Corporation | $19.18 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $17.51 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.99 | 2024 | Xifaxan, Trulance |
| Lilly USA, LLC | $14.80 | 2025 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Jamil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.